![Neil McFarlane](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Neil McFarlane
Directeur Général chez
ZEVRA THERAPEUTICS, INC.
Fortune : 4 M $ au 31/08/2026
Profil
Neil F.
McFarlane is President, Chief Executive Officer & Director at Zevra Therapeutics, Inc. since 2023.
Former roles include Chief Executive Officer at Adamas Pharmaceuticals LLC from 2019 to 2021, Independent Director at Collegium Pharmaceutical, Inc. from 2022 to 2024, Vice President & General Manager at UCB, Inc. from 2011 to 2016, and Chief Operating Officer at Travere Therapeutics, Inc. from 2016 to 2019.
Education includes undergraduate and graduate degrees from the University of Florida.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ZEVRA THERAPEUTICS, INC. 0,51 % | 06/04/2026 | 304 282 ( 0,51 % ) | 4 M $ | 31/08/2026 |
Postes actifs de Neil McFarlane
| Sociétés | Poste | Début |
|---|---|---|
| ZEVRA THERAPEUTICS, INC. | Directeur Général | 10/10/2023 |
Anciens postes connus de Neil McFarlane
| Sociétés | Poste | Fin |
|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC. | Directeur/Membre du Conseil | 28/07/2024 |
| ADAMAS PHARMACEUTICALS, INC. | Directeur Général | 01/11/2021 |
| TRAVERE THERAPEUTICS, INC. | Directeur des opérations | 31/05/2019 |
UCB, Inc.
 UCB, Inc. Financial ConglomeratesFinance Provides financial services | Corporate Officer/Principal | 01/01/2016 |
Formation de Neil McFarlane
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
54
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Collegium Pharmaceutical, Inc.
 Collegium Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Adamas Pharmaceuticals LLC
 Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets therapeutics for neurological diseases | Health Technology |
Zevra Therapeutics, Inc.
 Zevra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets proprietary prodrugs | Health Technology |
University of Florida
 University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCB, Inc.
UCB, Inc. Financial ConglomeratesFinance Provides financial services | Finance |
Travere Therapeutics, Inc.
 Travere Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in developing and delivering life-changing therapies to people living with rare kidney, liver & metabolic diseases | Health Technology |
